{"title": "Hannah Valantine", "author": null, "url": "https://stanfordhealthcare.org/doctors/v/hannah-valantine.html", "hostname": "stanfordhealthcare.org", "description": "Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.", "sitename": "Stanford Health Care", "date": "2022-02-04", "cleaned_text": "Biography Professional Summary Education & Certifications - Internship: St George's Hospital Medical School (1979) England - Residency: Guy's Hospital Medical School (1982) England - Fellowship: Stanford University Cardiovascular Medicine Fellowship (1986) CA - Fellowship: Hammersmith Hospital (1984) England - Residency: Brompton Hospital (1982) UK - Board Certification: Royal College of Physicians-U.K., Internal Medicine (1981) - Residency: St George's Hospital Medical School (1981) England - Medical Education: St George's Hospital Medical School (1978) England - MBBS, St Georges Hosp/London Univ, UK, Medicine (MD equivalent) (1978) - MRCP, London University, London, UK, Internal Medicine (1982) - Registrar, Hammersmith Hospital, London, UK, Cardiology Fellow (1984) - Fellow, Stanford University, Cardiology (1986) - MD, London University, London, UK, Cardiology (PhD equivalent) (1988) Awards & Memberships - Elected to Association of American Physicians, Association of American Physicians (2018) - Elected to the National Academy of Medicine in 2020., For both her pioneering research in organ transplantation and workforce diversity. (2020) - Exceptional Contributions to Education in Medicine, Stanford Department of Medicine (2006) - NIH Director's Pathfinder Award for Diversity in the Scientific Workforce, NIH (2010) - President's Awards for Excellence Through Diversity, Stanford University (2013) Administrative Appointments - President, Western State Affiliation, American Heart Association (2004 - 2005) - Professor of Medicine, Cardiovascular Medicine (2020 - Present) - Senior Associate Dean for Diversity and Faculty Development, School of Medicine (2005 - 2014) Publications - [Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis - A post hoc analysis of a randomized, placebo-controlled study](https://stanfordhealthcare.org/publications/223/2238.html) Valantine, H. A., Gao, S. Z., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P., ... Schroeder, J. S. (1999). Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis - A post hoc analysis of a randomized, placebo-controlled study. CIRCULATION, 100(1), 61-66. - [Neoral use in the cardiac transplant recipient](https://stanfordhealthcare.org/publications/611/6116.html) Valantine, H. (2000). Neoral use in the cardiac transplant recipient. TRANSPLANTATION PROCEEDINGS, 32(3A), 27S-44S. - [Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease?](https://stanfordhealthcare.org/publications/102/10239.html) Valantine, H., Zhu, D., Wen, P., Panchal, S. N., & Dai, X. (2001). Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease? Journal of Heart and Lung Transplantation , 20(2), 186-87. - [Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease - A prospective study](https://stanfordhealthcare.org/publications/110/11039.html) Valantine, H., Rickenbacker, P., Kemna, M., Hunt, S., CHEN, Y. D. I., Reaven, G., & Stinson, E. B. (2001). Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease - A prospective study. CIRCULATION, 103(17), 2144-52. - [Severe tricuspid regurgitation after heart transplantation](https://stanfordhealthcare.org/publications/121/12154.html) Chan, C. Y., Giannetti, N., Kato, T., Kornbluth, M., Oyer, P., Valantine, H. A., ... Hunt, S. A. (2001). Severe tricuspid regurgitation after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 20(7), 709-17. - [Detection and treatment of coronary artery disease in liver transplant candidates](https://stanfordhealthcare.org/publications/130/13074.html) Keeffe, B. G., Valantine, H., & Keeffe, E. B. (2001). Detection and treatment of coronary artery disease in liver transplant candidates. LIVER TRANSPLANTATION, 7(9), 755-761. - [Role of CMV in transplant coronary artery disease and survival after heart transplantation.](https://stanfordhealthcare.org/publications/131/13199.html) Valantine, H. A. (1999). Role of CMV in transplant coronary artery disease and survival after heart transplantation. Transplant Infectious Disease , 1, 25-30. - [Mild hyperhomocysteinemia is not associated with allograft coronary disease](https://stanfordhealthcare.org/publications/139/13901.html) Giannetti, N., Herity, N. A., Alimollah, A., Gao, S. Z., Schroeder, J. S., Yeung, A. C., ... Valantine, H. A. (2001). Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease. CLINICAL TRANSPLANTATION, 15(4), 247-252. - [Transplant coronary artery disease - A novel model independent of cellular alloimmune response](https://stanfordhealthcare.org/publications/141/14193.html) Cantin, B., Wen, P. Z., Zhu, D. N., Dai, M., Panchal, S. N., Billingham, M. E., ... Valantine, H. A. (2001). Transplant coronary artery disease - A novel model independent of cellular alloimmune response. CIRCULATION, 104(21), 2615-19. - [Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation - A comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone](https://stanfordhealthcare.org/publications/142/14297.html) Valantine, H. A., Luikart, H., Doyle, R., Theodore, J., Hunt, S., Oyer, P., ... Reitz, B. (2001). Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation - A comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus Zucker rats](https://stanfordhealthcare.org/publications/143/14300.html) Blankenberg, F. G., Wen, P. Z., Dai, M., Zhu, D. N., Panchal, S. N., Tait, J. F., ... Valantine, H. A. (2001). Detection of early atherosclerosis with - [Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection](https://stanfordhealthcare.org/publications/168/16894.html) Cantin, B., Giannetti, N., Parekh, H., Panchal, B. W. K., Najem, R., ... Valantine, H. A. (2002). Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection. CLINICAL TRANSPLANTATION, 16(3), 196-201. - [Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin](https://stanfordhealthcare.org/publications/173/17319.html) Cantin, B., Zhu, D., Wen, P., Panchal, S. N., Dai, X., Gwathmey, J. K., ... Valantine, H. A. (2002). Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(6), 637-43. - [Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection](https://stanfordhealthcare.org/publications/184/18448.html) Chan, M. C. Y., Kwok, B. W., Shiba, N., Cantin, B., Valantine, H. A., & Hunt, S. A. (2002). Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. TRANSPLANTATION PROCEEDINGS, 34(5), 1850-1852. - [Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy](https://stanfordhealthcare.org/publications/189/18977.html) Cantin, B., Zhu, D., Wen, P. Z., Panchal, S. N., Gwathmey, J. K., Reaven, G. M., & Valantine, H. A. (2002). Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(9), 1040-43. - [Post-operative conversion from cyclosporine to transplantation: A single-center experience](https://stanfordhealthcare.org/publications/245/24520.html) Cantin, B., Kwok, B. W. K., Shiba, N., Valantine, H. A., Hunt, S. A., & Chan, M. C. Y. (2003). Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: A single-center experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 22(7), 723-30. - [Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant \"atheroma\"](https://stanfordhealthcare.org/publications/284/28495.html) Valantine, H. A. (2003). Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant \"atheroma\". TRANSPLANTATION, 76(6), 891-99. - [Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era](https://stanfordhealthcare.org/publications/288/28812.html) Shiba, N., Chan, M. C. Y., Valantine, H. A., Gao, S. Z., Robbins, R. C., & Hunt, S. A. (2003). Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 22(10), 1098-1106. - [Cytomegalovirus infection impairs the nitric oxide asymmetric dimethylarginine in transplant arteriosclerosis](https://stanfordhealthcare.org/publications/307/30710.html) Weis, M., Kledal, T. N., LIN, K. Y., Panchal, S. N., Gao, S. Z., Valantine, H. A., ... Cooke, J. P. (2004). Cytomegalovirus infection impairs the nitric oxide synthase pathway - Role of asymmetric dimethylarginine in transplant arteriosclerosis. CIRCULATION, 109(4), 500-505. - [Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience](https://stanfordhealthcare.org/publications/310/31037.html) Shiba, N., Chan, M. C. Y., Kwok, B. W. K., Valantine, H. A., Robbins, R. C., & Hunt, S. A. (2004). Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 23(2), 155-64. - [The role of viruses in cardiac allograft vasculopathy](https://stanfordhealthcare.org/publications/315/31559.html) Valantine, H. A. (2004). The role of viruses in cardiac allograft vasculopathy. AMERICAN JOURNAL OF TRANSPLANTATION, 4(2), 169-77. - [Glucose intolerance, as reflected by hemoglobin A(1c) level, is associated with the incidence and severity of transplant coronary artery disease](https://stanfordhealthcare.org/publications/321/32180.html) Kato, T., Chan, M. C. Y., Gao, S. Z., Schroeder, J. S., Yokota, M., Murohara, T., ... Valantine, H. A. (2004). Glucose intolerance, as reflected by hemoglobin A(1c) level, is associated with the incidence and severity of transplant coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43(6), 1034-41. - [Cardiac H. (2004). Cardiac allograft vasculopathy after heart transplantation: Risk factors and management. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 23(5), S187-S193. - [INTRACORONARY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS - INVIVO EVIDENCE OF ANGIOGRAPHICALLY SILENT INTIMAL THICKENING](https://stanfordhealthcare.org/publications/363/36337.html) STGOAR, F. G., Pinto, F. J., Alderman, E. L., Valantine, H. A., Schroeder, J. S., Gao, S. Z., ... Popp, R. L. (1992). INTRACORONARY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS - INVIVO EVIDENCE OF ANGIOGRAPHICALLY SILENT INTIMAL THICKENING. CIRCULATION, 85(3), 979-987. - [COST COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION](https://stanfordhealthcare.org/publications/366/36665.html) Valantine, H., Keogh, A., McIntosh, N., Hunt, S., Oyer, P., & Schroeder, J. (1992). COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 11(1), 1-8. - [Certican (Everolimus) in heart transplantation: from clinical trial to clinical experience. Proceedings of a meeting, Vienna, Austria, September 9, 2004.](https://stanfordhealthcare.org/publications/405/40592.html) Certican (Everolimus) in heart transplantation: from clinical trial to clinical experience. Proceedings of a meeting, Vienna, Austria, September 9, 2004. (2005). Journal of Heart and Lung Transplantation , 24(4), S183-211. - [From clinical trials to clinical overview of Certican((R)) (everolimus) in heart transplantation](https://stanfordhealthcare.org/publications/405/40593.html) Valantine, H., & Zuckermann, A. (2005). From clinical trials to clinical practice: An overview of Certican((R)) (everolimus) in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(4), S185-S190. - [Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus): The Stanford University experience within the Certican Phase III clinical trial](https://stanfordhealthcare.org/publications/405/40594.html) Valantine, H. (2005). Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus): The Stanford University experience within the Certican Phase III clinical trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(4), S191-S195. - [Induction therapy for pediatric and adult heart transplantation: Comparison between OKT3 and daclizumab](https://stanfordhealthcare.org/publications/442/44292.html) Chin, C., Pittson, S., Luikart, H., Bernstein, D., Robbins, R., Reitz, B., ... Valantine, H. (2005). Induction therapy for pediatric and adult heart transplantation: Comparison between OKT3 and daclizumab. TRANSPLANTATION, 80(4), 477-81. - of long-term survivors of orthotopic heart transplantation](https://stanfordhealthcare.org/publications/448/44826.html) Ptaszek, L. M., Wang, P. J., Hunt, S. A., Valantine, H., Perlroth, M., & Al-Ahmad, A. (2005). Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. HEART RHYTHM, 2(9), 931-33. - [INTRACORONARY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE](https://stanfordhealthcare.org/publications/454/45458.html) Valantine, H., Pinto, F. J., STGOAR, F. G., Alderman, E. L., & Popp, R. L. (1992). INTRACORONARY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 11(3), S60-S64. - [Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis](https://stanfordhealthcare.org/publications/473/47305.html) Kuppahally, S. S., Hunt, S. A., Valantine, H. A., & Berry, G. J. (2006). Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(1), 144-47. - [Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients](https://stanfordhealthcare.org/publications/496/49673.html) Al-Khaldi, A., Weisshaar, D., Valantine, H. A., Oyer, P., Robbins, R. C., & Hunt, S. A. (2006). Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 6(5), 986-992. - [Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation](https://stanfordhealthcare.org/publications/499/49980.html) Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., Alfrey, E. J., ... Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139-46. - [Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic investigation for transplant arteriopathy II (PITA II) study](https://stanfordhealthcare.org/publications/517/51766.html) Fearon, W. F., Hirohata, A., Nakamura, M., Luikart, H., Lee, D. P., Vagelos, R. H., ... Yeung, A. C. (2006). Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic investigation for transplant arteriopathy II (PITA II) study. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(7), 765-71. - [Acute rejection and cardiac allograft vascular by suppression of subclinical cytomegalovirus infection](https://stanfordhealthcare.org/publications/526/52669.html) Potena, L., Holweg, C. T. H., Weisshaar, D., Narasimhan, B., ... Valantine, H. A. (2006). Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus TRANSPLANTATION, 82(3), 398-405. - allograft disease](https://stanfordhealthcare.org/publications/539/53966.html) Tu, W., Potena, L., Stepick-Biek, P., Liu, L., Dionis, K. Y., Luikart, H., ... Lewis, D. B. (2006). T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. 114(15), 1608-15. - [Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy](https://stanfordhealthcare.org/publications/549/54921.html) Haddad, F., Perez, M., Fleischmann, D., Valantine, H., & Hunt, S. A. (2006). Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(11), 1367-70. - [Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: Impact of acute disease versus subclinical infection](https://stanfordhealthcare.org/publications/556/55697.html) Cooke, M. E., Potena, L., Luikart, H., & Valantine, H. A. (2006). Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: Impact of acute disease versus subclinical infection. TRANSPLANTATION, 82(11), 1419-24. - [Molecular testing in the management of cardiac transplant recipients: Initial clinical experience](https://stanfordhealthcare.org/publications/558/55843.html) Starling, R. C., Pham, M., Valantine, H., Miller, L., Eisen, H., Rodriguez, E. R., ... Deng, M. C. (2006). Molecular testing in the management of cardiac transplant recipients: Initial clinical experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(12), 1389-95. - [Pulmonary nocardiosis in a heart transplant patient: Case report and review of the literature](https://stanfordhealthcare.org/publications/565/56511.html) Haddad, F., Hunt, S. A., Perlroth, M., Valantine, H., Doyle, R., & Montoya, J. (2007). Pulmonary nocardiosis in a heart transplant patient: Case report and review of the literature. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(1), 93-97. - [NITROGLYCERIN-INDUCED CORONARY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS EVALUATION WITH INVIVO INTRACORONARY ULTRASOUND](https://stanfordhealthcare.org/publications/571/57110.html) Pinto, F. J., STGOAR, F. G., Fischell, T. A., Stadius, M. L., Valantine, H. A., Alderman, E. L., & Popp, R. L. (1992). NITROGLYCERIN-INDUCED CORONARY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS - EVALUATION WITH INVIVO INTRACORONARY ULTRASOUND. CIRCULATION, 85(1), 69-77. - [Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation](https://stanfordhealthcare.org/publications/585/58570.html) Biadi, O., Potena, L., Fearon, W. F., Luikart, H. I., Yeung, A., Ferrara, R., ... Valantine, H. A. (2007). Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(4), 324-30. - [Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis](https://stanfordhealthcare.org/publications/586/58640.html) Potena, L., Holweg, C. T. J., Vana, M. L., Bashyam, L., Rajamani, J., McCormick, A. L., ... Mocarski, E. S. (2007). Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. JOURNAL OF CLINICAL MICROBIOLOGY, 45(6), 1804-10. - [Changes in coronary arterial dimensions early after cardiac transplantation](https://stanfordhealthcare.org/publications/587/58718.html) Fearon, W. F., Potena, L., Hirohata, A., Sakurai, R., Yamasaki, M., Luikart, H., ... Valantine, H. A. (2007). Changes in coronary arterial dimensions early after cardiac transplantation. TRANSPLANTATION, 83(6), 700-705. - [Changes in coronary anatomy and physiology after heart transplantation](https://stanfordhealthcare.org/publications/599/59945.html) Hirohata, A., Nakamura, M., Waseda, K., Honda, Y., Lee, D. P., Vagelos, R. H., ... Fearon, W. F. (2007). Changes in coronary anatomy and physiology after heart transplantation. AMERICAN JOURNAL OF CARDIOLOGY, 99(11), 1603-7. - [Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology](https://stanfordhealthcare.org/publications/600/60071.html) Valantine, H. (2007). Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(6), 557-64. - [Cytomegalovirus-associated allograft rejection in heart transplant L., & Valantine, H. A. (2007). Cytomegalovirus-associated allograft rejection in heart transplant patients. CURRENT OPINION IN INFECTIOUS DISEASES, 20(4), 425-431. - [Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial](https://stanfordhealthcare.org/publications/617/61797.html) Pham, M. X., Deng, M. C., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. (2007). Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(8), 808-14. - [Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness](https://stanfordhealthcare.org/publications/626/62655.html) Kuppahally, S. S., Valantine, H. A., Weisshaar, D., Parekh, H., Hung, Y. Y., Haddad, F., ... Hunt, S. A. (2007). Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. AMERICAN JOURNAL OF TRANSPLANTATION, 7(10), 2388-95. - [Determinants of lumen loss between years 1 and 2 after cardiac transplantation](https://stanfordhealthcare.org/publications/645/64527.html) Sakurai, R., Yamasaki, M., Nakamura, M., Hirohata, A., Honda, Y., Bonneau, H. N., ... Fearon, W. F. (2007). Determinants of lumen loss between years 1 and 2 after cardiac transplantation. TRANSPLANTATION, 84(9), 1097-1102. - K., Holweg, C., Luikart, H., Chin, C., ... Cooke, of rapamycin therapy on coronary artery physiology early after cardiac transplantation](https://stanfordhealthcare.org/publications/693/69348.html) Sinha, S. S., Pham, M. X., Vagelos, R. H., Perlroth, M. G., Hunt, S. A., Lee, D. P., ... Fearon, W. F. (2008). Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. AMERICAN HEART JOURNAL, 155(5). - [Twenty-year survivors of heart transplantation at Stanford University](https://stanfordhealthcare.org/publications/709/70944.html) Deuse, T., Haddad, F., Pham, M., Hunt, S., Valantine, H., BATES, M. J., ... Reitz, B. A. (2008). Twenty-year survivors of heart transplantation at Stanford University. AMERICAN JOURNAL OF TRANSPLANTATION, 8(9), 1769-74. - [New developments in immunosuppressive therapy for heart transplantation](https://stanfordhealthcare.org/publications/793/79339.html) Khush, K. K., & Valantine, H. A. (2009). New developments in immunosuppressive therapy for heart transplantation. EXPERT OPINION ON EMERGING DRUGS, 14(1), 1-21. - [Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection](https://stanfordhealthcare.org/publications/800/80037.html) Haddad, F., Fisher, P., Pham, M., Berry, G., Weisshaar, D., Kuppahally, S., ... Hunt, S. (2009). Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(4), 312-19. - [SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE - TEMPORAL CORRELATION WITH ENDOMYOCARDIAL BIOPSY](https://stanfordhealthcare.org/publications/830/83072.html) Valantine, H. A., YEOH, T. K., Gibbons, R., McCarthy, P., Stinson, E. B., Billingham, M. E., & Popp, R. L. (1991). SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE - TEMPORAL CORRELATION WITH ENDOMYOCARDIAL BIOPSY. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 10(5), 757-765. - [Changing trends in infectious disease in heart transplantation](https://stanfordhealthcare.org/publications/860/86045.html) Haddad, F., Deuse, T., Pham, M., Khazanie, P., Rosso, F., Luikart, H., ... Montoya, J. G. (2010). Changing trends in infectious disease in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(3), 306-15. - [CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION](https://stanfordhealthcare.org/publications/864/86482.html) YEOH, T. K., Kramer, M. R., Marshall, S., Theodore, J., Gibbons, R., Valantine, H. A., & Starnes, V. A. (1991). CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 1226-27. - [Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation](https://stanfordhealthcare.org/publications/920/92018.html) Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., Cappola, T. P., ... Valantine, H. A. (2010). Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 362(20), 1890-1900. - [FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS](https://stanfordhealthcare.org/publications/921/92157.html) Dibiase, A., Tse, T. M., Schnittger, I., Wexler, L., Stinson, E. B., & Valantine, H. A. (1991). FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS. AMERICAN JOURNAL OF CARDIOLOGY, 67(16), 1385-89. - [Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions](https://stanfordhealthcare.org/publications/971/97184.html) Chen, R., Sigdel, T. K., Li, L., Kambham, N., Dudley, J. T., Hsieh, S.-C., ... Butte, A. J. (2010). Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection Other Conditions. PLOS COMPUTATIONAL BIOLOGY, 6(9). - [Academic Couples: Implications for Medical School Faculty Recruitment and Retention](https://stanfordhealthcare.org/publications/102/102975.html) Girod, S., Gilmartin, S. K., Valantine, H., & Schiebinger, L. (2011). Academic Couples: Implications for Medical School Faculty Recruitment and Retention. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 212(3), 310-19. - [Universal noninvasive detection of solid organ transplant rejection](https://stanfordhealthcare.org/publications/105/105484.html) Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011). Universal noninvasive detection of solid organ transplant rejection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(15), 6229-34. - [Impact of Donor-Transmitted Atherosclerosis Ultrasound R., Y., Bonneau, H. N., Luikart, H., ... Fearon, W. F. (2011). Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings Intravascular Ultrasound Analysis. TRANSPLANTATION, 91(12), 1406-11. - [Identification and of Acute Cardiac Rejection by Intragraft Transcriptional Profiling](https://stanfordhealthcare.org/publications/107/107576.html) Holweg, C. T. J., Potena, L., Luikart, H., Yu, T., Berry, G. J., Cooke, J. P., ... Mocarski, E. S. (2011). Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling. CIRCULATION, 123(20), 2236-U154. - [Proliferation signal inhibitors malignancies transplantation: practical clinical management questions](https://stanfordhealthcare.org/publications/108/108017.html) Epailly, E., Albanell, J., Andreassen, A., Bara, C., Campistol, J. M., Delgado, J. F., ... Potena, L. (2011). Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. CLINICAL TRANSPLANTATION, 25(5), E475-E486. - [Decisions, Decisions: How Program Diversity Influences Residency Program Choice](https://stanfordhealthcare.org/publications/108/108811.html) Ku, M. C., Li, Y. E., Prober, C., Valantine, H., & Girod, S. C. (2011). Decisions, Decisions: How Program Diversity Influences Residency Program Choice. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 213(2), 294-305. - [Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects.](https://stanfordhealthcare.org/publications/114/114422.html) Valantine, H. A., Hatle, L. K., Appleton, C. P., Gibbons, R., & Popp, R. L. (1990). Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects. Journal of the American Society of Echocardiography , 3(4), 276-284. - [CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES](https://stanfordhealthcare.org/publications/125/125824.html) Edwards, B. S., Hunt, S. A., Fowler, M. B., Valantine, H. A., Stinson, E. B., & Schroeder, J. S. (1990). CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES. AMERICAN JOURNAL OF CARDIOLOGY, 65(7), 501-4. - [SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE RECOGNITION OF ACUTE REJECTION](https://stanfordhealthcare.org/publications/125/125941.html) Masuyama, T., Valantine, H. A., Gibbons, R., Schnittger, I., & Popp, R. L. (1990). SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE RECOGNITION OF ACUTE REJECTION. CIRCULATION, 81(3), 829-39. - [Transdisciplinary translational science and the case of preterm birth](https://stanfordhealthcare.org/publications/126/126066.html) Stevenson, D. K., Shaw, G. M., Wise, P. H., Norton, M. E., Druzin, M. L., Valantine, H. A., & McFarland, D. A. (2013). Transdisciplinary translational science and the case of preterm birth. JOURNAL 33(4), 251-58. - [LEFT-VENTRICULAR AFTER CARDIAC TRANSPLANTATION](https://stanfordhealthcare.org/publications/132/132916.html) STGOAR, F. G., Gibbons, R., Schnittger, I., Valantine, H. A., & Popp, R. L. (1990). LEFT-VENTRICULAR DIASTOLIC FUNCTION - DOPPLER ECHOCARDIOGRAPHIC CHANGES SOON AFTER CARDIAC TRANSPLANTATION. CIRCULATION, 82(3), 872-78. - [Long-term management and results in heart transplant recipients.](https://stanfordhealthcare.org/publications/133/133028.html) Valantine, H. A. (1990). Long-term management and results in heart transplant recipients. Cardiology Clinics, 8(1), 141-148. - [INCREASED BETA-RECEPTOR DENSITY AND IMPROVED TO METOPROLOL THERAPY IN HEART-FAILURE FROM DILATED CARDIOMYOPATHY](https://stanfordhealthcare.org/publications/133/133835.html) HEILBRUNN, S. M., Shah, P., Bristow, M. R., Valantine, H. A., Ginsburg, R., & Fowler, M. B. (1989). INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYNAMIC-RESPONSE TO CATECHOLAMINE STIMULATION DURING LONG-TERM THERAPY IN LONG-TERM RECIPIENTS - ETIOLOGY AND PROGNOSIS OF RESTRICTIVE-CONSTRICTIVE PHYSIOLOGY](https://stanfordhealthcare.org/publications/134/134413.html) Valantine, H. A., Appleton, C. P., Hatle, L. K., Hunt, S. A., Billingham, M. E., Shumway, N. E., ... Popp, R. L. (1989). A HEMODYNAMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG-TERM CARDIAC ALLOGRAFT RECIPIENTS - ETIOLOGY AND PROGNOSIS OF RESTRICTIVE-CONSTRICTIVE PHYSIOLOGY. CIRCULATION, 66-75. - [INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS](https://stanfordhealthcare.org/publications/134/134445.html) Valantine, H. A., Hunt, S. A., Gibbons, R., Billingham, M. E., Stinson, E. B., & Popp, R. L. (1989). INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS. CIRCULATION, 79(3), 603-609. - [FREQUENCY OF FAMILIAL NATURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN THIS SUBSET](https://stanfordhealthcare.org/publications/134/134476.html) Valantine, H. A., Hunt, S. A., Fowler, M. B., Billingham, M. E., & Schroeder, J. S. (1989). FREQUENCY OF FAMILIAL NATURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN THIS SUBSET. JOURNAL OF CARDIOLOGY, 63(13), 959-63. - [CARDIAC TRANSPLANTATION](https://stanfordhealthcare.org/publications/134/134638.html) Valantine, H. A., & Schroeder, J. S. (1989). CARDIAC TRANSPLANTATION. INTENSIVE CARE MEDICINE, 15(5), 283-289. - [RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION](https://stanfordhealthcare.org/publications/134/134642.html) Valantine, H. A., & Billingham, M. E. (1989). RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION. JOURNAL OF HEART TRANSPLANTATION, 8(4), 337-341. - [Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.](https://stanfordhealthcare.org/publications/135/135359.html) Gao, S. Z., Schroeder, J. S., Alderman, E. L., Hunt, S. A., Valantine, H. A., WIEDERHOLD, V., & Stinson, E. B. (1989). Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation, 80(5), III100-5. - [Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection.](https://stanfordhealthcare.org/publications/138/138169.html) Valantine, H. A., Fowler, M. B., Hunt, S. A., NAASZ, C., Hatle, L. K., Billingham, M. E., ... Popp, R. L. (1987). Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation, 76(5), V86-92. - [Cardiac sarcoidosis: response to steroids and H. A., Tazelaar, H. D., Macoviak, J., MULLIN, A. V., Hunt, S. A., Fowler, M. B., ... Schroeder, J. S. (1987). Cardiac sarcoidosis: response to steroids and transplantation. Journal of Heart Transplantation, 6(4), 244-50. - [PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS - EVIDENCE FOR A BENEFICIAL EFFECT OF HYPERIMMUNE GLOBULIN](https://stanfordhealthcare.org/publications/150/150029.html) Valantine, H. A. (1995). PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS - EVIDENCE FOR A BENEFICIAL EFFECT OF HYPERIMMUNE GLOBULIN. TRANSPLANTATION PROCEEDINGS, 27(5), 49-57. - [MAGNETIC-RESONANCE IN LIVER-TRANSPLANTATION CANDIDATES](https://stanfordhealthcare.org/publications/150/150854.html) Kuo, P. C., Alfrey, E. J., Li, K., Vagelos, R., Valantine, H., Garcia, G., & Dafoe, D. C. (1995). MAGNETIC-RESONANCE IMAGING-DERIVED PARAMETER OF PORTAL 118(4), 685-692. INTERVAL RENAL-TRANSPLANTATION ALLOGRAFT RECIPIENTS](https://stanfordhealthcare.org/publications/151/151109.html) Kuo, P. C., Luikart, H., BUSSEHENRY, S., Hunt, S. A., Valantine, H. A., Stinson, E. B., ... Dafoe, D. C. (1995). CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS. CLINICAL TRANSPLANTATION, 9(2), 92-97. - [CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORONARY-ARTERY DISEASE AS ASSESSED BY INTRACORONARY ULTRASOUND AND CORONARY ANGIOGRAPHY](https://stanfordhealthcare.org/publications/151/151436.html) RICHENBACHER, P. R., Pinto, F. J., Lewis, N. P., Hunt, S. A., Gamberg, P., Alderman, E. L., ... Valantine, H. A. (1995). CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORONARY-ARTERY DISEASE AS ASSESSED BY INTRACORONARY ULTRASOUND AND CORONARY ANGIOGRAPHY. AMERICAN JOURNAL OF CARDIOLOGY, 76(5), 340-45. - [Distribution and morphologic features of coronary disease in cardiac allografts: an intracoronary ultrasound study.](https://stanfordhealthcare.org/publications/152/152044.html) Chenzbraun, A., Pinto, F. J., Alderman, E. L., Botas, J., Oesterle, S. N., Schroeder, J. S., ... Popp, R. L. (1995). Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. Journal of the American Society of Echocardiography , 8(1), 1-8. - [INCIDENCE AND SEVERITY OF TRANSPLANT CORONARY-ARTERY DISEASE EARLY AND UP TO 15 YEARS AFTER TRANSPLANTATION AS DETECTED BY INTRAVASCULAR ULTRASOUND](https://stanfordhealthcare.org/publications/152/152679.html) Rickenbacher, P. R., Pinto, F. J., Chenzbraun, A., Botas, J., Lewis, N. P., Alderman, E. L., ... Yeung, A. C. (1995). INCIDENCE AND SEVERITY OF TRANSPLANT CORONARY-ARTERY DISEASE EARLY AND UP TO 15 YEARS AFTER TRANSPLANTATION AS DETECTED BY INTRAVASCULAR ULTRASOUND. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 25(1), - [CARDIAC ALLOGRAFT VASCULAR-DISEASE AND INFLAMMATORY CELL PHENOTYPES ON ENDOMYOCARDIAL BIOPSY](https://stanfordhealthcare.org/publications/153/153292.html) Deng, M. C., Bell, S., Huie, P., Pinto, F., Hunt, S. A., Stinson, E. B., ... Valantine, H. A. (1995). CARDIAC ALLOGRAFT VASCULAR-DISEASE - RELATIONSHIP TO MICROVASCULAR CELL-SURFACE MARKERS ON ENDOMYOCARDIAL BIOPSY. CIRCULATION, 91(6), 1647-54. - [IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION](https://stanfordhealthcare.org/publications/153/153754.html) Valantine, H., Hunt, S., Gamberg, P., Miller, J., & Luikart, H. (1994). IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 26(5), 2710-12. - [CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT PATIENTS - A PILOT-STUDY USING IN-SITU HYBRIDIZATION](https://stanfordhealthcare.org/publications/153/153756.html) Valantine, H., Johnson, F., Dong, C., Lewis, N., Tovey, D., Huie, P., ... Sibley, R. (1994). CYTOKINES MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE-TREATED PATIENTS TRANSPLANTATION PROCEEDINGS, 26(5), 2852-53. - [EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS - A COMPARISON WITH ANGIOGRAPHY AND INTRACORONARY ULTRASONOGRAPHY](https://stanfordhealthcare.org/publications/153/153790.html) COLLINGS, C. A., Pinto, F. J., H. A., Popylisen, S., Puryear, J. V., & Schnittger, I. (1994). EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS - A COMPARISON WITH ANGIOGRAPHY AND INTRACORONARY ULTRASONOGRAPHY. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 13(4), 604-13. - [FEASIBILITY OF SERIAL INTRACORONARY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL PROLIFERATION IN CARDIAC TRANSPLANT RECIPIENTS](https://stanfordhealthcare.org/publications/153/153848.html) Pinto, F. J., Chenzbraun, A., Botas, J., Valantine, H. A., STGOAR, F. G., Alderman, E. L., ... Popp, R. L. (1994). FEASIBILITY OF SERIAL INTRACORONARY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL PROLIFERATION IN CARDIAC TRANSPLANT RECIPIENTS. CIRCULATION, 90(5), 2348-2355. - [Cytokine gene expression in human cardiac allograft recipients.](https://stanfordhealthcare.org/publications/154/154191.html) Wu, C. J., Kurbegov, D., C., Valantine, H., ... CLAYBERGER, C. (1994). Cytokine gene in Transplant M. S., Valantine, H. A., Hunt, S. A., Schroeder, J. S., CHEN, Y. D. I., & Reaven, G. M. (1994). METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS. AMERICAN HEART JOURNAL, 128(1), 68-72. - [CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA](https://stanfordhealthcare.org/publications/154/154506.html) Sarris, G. E., Moore, K. A., Schroeder, J. S., Hunt, S. A., Fowler, M. B., VALANTINE, H. B., ... Shumway, N. E. (1994). CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 108(2), 240-52. - [RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMONARY-HYPERTENSION](https://stanfordhealthcare.org/publications/155/155260.html) Kramer, M. R., Valantine, H. A., Marshall, S. E., Starnes, V. A., & Theodore, J. (1994). RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMONARY-HYPERTENSION. AMERICAN JOURNAL OF CARDIOLOGY, 73(7), 494-500. - [INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORONARY-ARTERY DISEASE - A NEW APPROACH TO ANALYSIS](https://stanfordhealthcare.org/publications/156/156528.html) Gao, S. Z., Schroeder, J. S., Hunt, S. A., Valantine, H. A., Hill, I. R., & Stinson, E. B. (1993). INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORONARY-ARTERY DISEASE - A NEW APPROACH TO ANALYSIS. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 12(6), 1029-35. - [PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORONARY ULTRASOUND AFTER CARDIAC TRANSPLANTATION](https://stanfordhealthcare.org/publications/158/158085.html) Rickenbacher, P. R., Pinto, F. J., Lewis, N. P., Hunt, S. A., Alderman, E. L., Schroeder, J. S., ... Valantine, H. A. (1995). PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORONARY ULTRASOUND AFTER CARDIAC TRANSPLANTATION. CIRCULATION, 92(12), 3445-52. - [Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation](https://stanfordhealthcare.org/publications/158/158268.html) Wagner, J. A., Ross, H., Hunt, S., Gamberg, P., Valantine, H., Merigan, T. C., & Stinson, E. B. (1995). Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. TRANSPLANTATION. CHICAGO,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS,ILLINOIS: WILLIAMS & WILKINS. - [The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction](https://stanfordhealthcare.org/publications/158/158269.html) Alpert, S., Lewis, N. P., Ross, H., Fowler, M., & Valantine, H. A. (1995). The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction. TRANSPLANTATION, 60(12), 1478-85. - [Coronary artery intimal thickening in the transplanted heart - An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors](https://stanfordhealthcare.org/publications/158/158407.html) Rickenbacher, P. R., Kemna, M. S., Pinto, F. J., Hunt, S. A., Alderman, E. L., Schroeder, J. S., ... Valantine, H. A. (1996). Coronary artery intimal thickening in the transplanted heart - An in vivo intracoronary ultrasound study of immunologic and metabolic risk 61(1), 46-53. - [Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle](https://stanfordhealthcare.org/publications/159/159178.html) Lewis, N. P., Tsao, P. S., Rickenbacher, P. R., Xue, C., Johns, R. A., Haywood, G. A., ... Fowler, M. B. (1996). Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. CIRCULATION, 93(4), 720-29. - [Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound](https://stanfordhealthcare.org/publications/159/159809.html) Yeung, A. C., Davis, S. F., Hauptman, P. J., Kobashigawa, J. A., Miller, L. W., Valantine, H. A., ... Wilensky, R. (1995). Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound. JOURNAL OF HEART AND LUNG TRANSPLANTATION. ST LOUIS,MO,MO: ELSEVIER SCIENCE INC. - [Role of lipids in allograft vascular disease: detected intravascular ultrasound](https://stanfordhealthcare.org/publications/159/159810.html) Valantine, A. of vascular disease: A multicenter study of intimal thickening detected by intravascular ultrasound. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14(6), S234-S237. - [Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation.](https://stanfordhealthcare.org/publications/161/161319.html) Ross, H. J., Gullestad, L., Hunt, S. A., TOVEY, D. A., PURYEAR, J. B., McMillan, A., ... Valantine, H. A. (1996). Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. Circulation, 94(9), II289-93. - [Volume-mediated pulmonary responses in liver transplant candidates](https://stanfordhealthcare.org/publications/162/162148.html) Kuo, P. C., Schroeder, R. A., Vagelos, R. H., Valantine, H., Garcia, G., Alfrey, E. J., ... Dafoe, D. C. (1996). Volume-mediated pulmonary responses in liver transplant candidates. CLINICAL TRANSPLANTATION, 10(6), 521-527. - [Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: A comparative study](https://stanfordhealthcare.org/publications/162/162657.html) Ross, H. J., Gullestad, L., Pak, J., Slauson, S., Valantine, H. A., & Hunt, S. A. (1997). Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: A comparative study. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 16(2), 179-89. - [Significant reduction in the number of fungal after lung-, and Gamberg, P., Nitschke, H., Hunt, S., Oyer, P. E., & Reitz, B. A. (1997). Significant reduction in the number of fungal infections after lung-, heart-lung, and heart B prophylaxis. TRANSPLANTATION PROCEEDINGS, 29(1-2), 627-28. - [Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life](https://stanfordhealthcare.org/publications/163/163439.html) Rickenbacher, P. R., Lewis, N. P., Valantine, H. A., Luikart, H., Stinson, E. B., & Hunt, S. A. (1997). Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life. EUROPEAN HEART JOURNAL, 18(5), 870-878. - [Importance of decreased heart rate in predicting transplant coronary artery disease](https://stanfordhealthcare.org/publications/165/165696.html) Gullestad, L., Ross, H., Myers, J., Hoang, K., Hunt, S., Stinson, E. B., & Valentine, H. A. (1997). Importance of decreased heart rate in predicting transplant coronary artery disease. CLINICAL TRANSPLANTATION, 11(6), 628-32. - [Individualizing immunosuppression for heart transplantation: Strategies next decade](https://stanfordhealthcare.org/publications/165/165730.html) Valantine, H. A. (1997). Individualizing immunosuppression for heart transplantation: Strategies for the next PROCEEDINGS, 29(8A), 5S-8S. - [Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity](https://stanfordhealthcare.org/publications/166/166949.html) Lopez, F. A., Crowley, R. S., Wastila, L., Valantine, H. A., & Remington, J. S. (1998). Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 17(3), 321-324. - [Diabetes and dyslipidemia - A new model for transplant coronary artery disease](https://stanfordhealthcare.org/publications/167/167507.html) Hoang, K., Chen, I., Reaven, G., Zhang, L. N., Ross, H., Billingham, M., & Valantine, H. (1998). Diabetes and dyslipidemia - A new model for transplant coronary artery disease. CIRCULATION, 97(21), 2160-68. - [Changes in the anatomy and physiology of the coronary circulation after cardiac transplantation: Novel structural and physiologic evidence of cardiac transplant arteriopathy](https://stanfordhealthcare.org/publications/179/179368.html) Hirohata, A., Nakamura, M., Waseda, K., Valantine, H. A., Hunt, S. A., Honda, Y., ... Fearon, W. F. (2005). Changes in the anatomy and physiology of the coronary circulation after cardiac transplantation: Novel structural and physiologic evidence of cardiac transplant arteriopathy. CIRCULATION, 112(17), U517-U517. of donor-transmitted Yamasaki, M., Sakurai, R., Hirohata, A., Honda, Y., Yock, P. G., Fitzgerald, P. J., ... Fearon, W. F. (2006). Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy; a key role in preseving epicardial artery flow early after cardiac transplantation](https://stanfordhealthcare.org/publications/179/179375.html) Sakurai, R., Yamasaki, M., Potena, L., Hirohata, A., Honda, Y., Yock, P. G., ... Fearon, W. F. (2007). Aggressive prophylaxis against cytomegalovirus plays a key role in preseving epicardial artery flow early after cardiac transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49(9), 78A-78A. - [Mycophenolate mofetil of multicenter trial](https://stanfordhealthcare.org/publications/196/196485.html) J. A., M., MENTZER, R. M., Valantine, H. A., Bourge, R. C., Mehra, M. R., ... Gordon, R. D. (2006). Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: Reanalysis of the multicenter trial. AMERICAN JOURNAL OF TRANSPLANTATION, 993-97. - [Heart Transplants Are Genome Transplants: Universal Noninvasive Detection of Solid Organ Transplant Rejection](https://stanfordhealthcare.org/publications/201/201003.html) Khush, K. K., Snyder, T. M., Quake, S. R., & Valantine, H. A. (2011). Heart Transplants Are Genome Transplants: Universal Noninvasive Detection of Solid Organ Transplant Rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S186-S187. - [CHANGES IN DOPPLER ECHOCARDIOGRAPHIC INDEXES OF LEFT-VENTRICULAR FUNCTION AS POTENTIAL MARKERS OF ACUTE CARDIAC REJECTION](https://stanfordhealthcare.org/publications/203/203467.html) Valantine, H. A., Fowler, M. B., Hunt, S. A., NAASZ, C., Hatle, L. K., Billingham, M. E., ... Popp, R. L. (1987). CHANGES IN DOPPLER ECHOCARDIOGRAPHIC INDEXES OF LEFT-VENTRICULAR FUNCTION AS POTENTIAL MARKERS OF ACUTE CARDIAC REJECTION. CIRCULATION, 76(5), 86-92. - [INFLUENCE OF RECURRENT REJECTION EPISODES ON LEFT-VENTRICULAR FUNCTION OF THE TRANSPLANTED HEART](https://stanfordhealthcare.org/publications/203/203481.html) Valantine, H. A., Appleton, C. P., Hunt, S. A., Billingham, M. E., Stinson, E. B., & Popp, R. L. (1987). INFLUENCE OF RECURRENT REJECTION EPISODES ON LEFT-VENTRICULAR FUNCTION OF THE TRANSPLANTED HEART. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 9(2), A221-A221. - [CORRELATION OF INTRACORONARY Bell, P., Pinto, F., STGOAR, F., Hunt, S., ... Popp, R. (1992). CORRELATION OF VASCULAR ENDOTHELIAL ANTIGEN RV ENDOMYOCARDIAL BIOPSY WITH INTRACORONARY ARTERY ULTRASOUND 86(4), 357-57. - [DOPPLER ECHO INDEXES OF LV-FILLING ASSOCIATED HEMODYNAMICS FOLLOWING METOPROLOL THERAPY IN L., HEILBRUNN, S., Oldershaw, P., Popp, R. L., & Fowler, M. B. (1987). DOPPLER ECHO INDEXES OF LV-FILLING ASSOCIATED WITH IMPROVED HEMODYNAMICS FOLLOWING THERAPY DURING ACUTE CARDIAC ALLOGRAFT-REJECTION](https://stanfordhealthcare.org/publications/203/203502.html) Valantine, H. A., Redington, A. N., Oldershaw, P. J., Fowler, M. B., Hatle, L., Hunt, S. A., ... Popp, R. L. (1987). DOPPLER AND M-MODE ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR FUNCTION DURING ACUTE CARDIAC ALLOGRAFT-REJECTION. PORTLAND PRESS. - [CHANGES IN DOPPLER ECHOCARDIOGRAPHIC INDEXES OF LEFT-VENTRICULAR FUNCTION AS POTENTIAL MARKERS OF ACUTE REJECTION](https://stanfordhealthcare.org/publications/203/203512.html) Valantine, H. A., Fowler, M. B., Hunt, S. A., NAASZ, C., Hatle, L. K., Stinson, E. B., ... Popp, R. L. (1986). CHANGES IN DOPPLER ECHOCARDIOGRAPHIC INDEXES OF LEFT-VENTRICULAR FUNCTION AS POTENTIAL MARKERS OF ACUTE REJECTION. CIRCULATION, 74(4), 159-59. - [CHANGES IN DOPPLER AND M-MODE FUNCTION DURING ACUTE CARDIAC ALLOGRAFT-REJECTION](https://stanfordhealthcare.org/publications/203/203529.html) Valantine, H. A., Oldershaw, P. J., Fowler, M. B., Gibson, D. G., Hatle, L., Hunt, S. A., ... Popp, R. L. (1987). CHANGES IN DOPPLER AND M-MODE ECHOCARDIOGRAPHIC INDEXES OF LEFT-VENTRICULAR FUNCTION DURING ACUTE CARDIAC ALLOGRAFT-REJECTION. BRITISH HEART JOURNAL, 57(1), 86-86. - [PREVALENCE OF ACCELERATED CORONARY-ARTERY DISEASE IN HEART-TRANSPLANT SURVIVORS - COMPARISON OF CYCLOSPORINE AND AZATHIOPRINE REGIMENS](https://stanfordhealthcare.org/publications/204/204249.html) Gao, S. Z., Schroeder, J. S., Alderman, E. L., Hunt, S. A., Valantine, H. A., WIEDERHOLD, V., & Stinson, E. B. (1989). PREVALENCE OF ACCELERATED CORONARY-ARTERY DISEASE IN HEART-TRANSPLANT SURVIVORS - COMPARISON OF CYCLOSPORINE AND AZATHIOPRINE REGIMENS. 100-105. E., HEILBRUNN, S. M., MULLIN, A. V., MCCRORY, S. P., Schroeder, J. S., & Fowler, M. B. (1986). RESPONSE TO BETA-BLOCKERS IN DILATED CARDIOMYOPATHY PREDICTED BY MYOCARDIAL BY TC-99M ISONITRILE SCINTIGRAPHY](https://stanfordhealthcare.org/publications/204/204254.html) Lucas, J. R., Valantine, H. A., Hunt, S., FUJIK, C. Y., Goris, M. L., & Schroeder, J. S. (1991). NONINVASIVE DIAGNOSIS OF TRANSPLANT CORONARY-ARTERY DISEASE BY TC-99M ISONITRILE SCINTIGRAPHY. CLINICAL RESEARCH, 39(2), A233-A233. ACCELERATED TRANSPLANT CORONARY-ARTERY DISEASE](https://stanfordhealthcare.org/publications/204/204264.html) Valantine, H., McCook, O., Pinto, F. J., Hunt, S., Schroeder, J. S., & Stinson, E. B. (1994). INTERLEUKIN-6 - POTENTIAL ROLE IN ACCELERATED TRANSPLANT CORONARY-ARTERY DISEASE. CIRCULATION, 90(4), 94-94. - [Hyperhomocysteinemia is common in heart transplant patients but is not correlated with transplant coronary artery disease](https://stanfordhealthcare.org/publications/204/204296.html) Giannetti, N., Alimollah, A., Gao, S. Z., Schroeder, J. S., Hunt, S. A., & Valantine, H. A. (1999). Hyperhomocysteinemia is common in heart transplant patients but is not correlated with transplant coronary artery disease. TRANSPLANTATION, 67(7), S107-S107. - [CARDIAC TRANSPLANTATION IN CHILDREN AND ADOLESCENTS](https://stanfordhealthcare.org/publications/204/204398.html) Starnes, V. A., Stinson, E. B., Oyer, P. E., Valantine, H., Baldwin, J. C., Hunt, S. A., & Shumway, N. E. (1987). CARDIAC TRANSPLANTATION IN CHILDREN AND ADOLESCENTS. CIRCULATION, 76(5), 43-49. - [Early Doppler echocardiographic: Dysfunction is associated with an increased mortality after orthotopic cardiac transplantation](https://stanfordhealthcare.org/publications/204/204627.html) Ross, H. J., Gullestad, L., Hunt, S. A., TOVEY, D. A., PURYEAR, J. B., McMillan, A., ... Valantine, H. A. (1996). Early Doppler echocardiographic: Dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. CIRCULATION, 94(9), 289-93. - [Leukocyte gene expression signature of CMV viremia in cardiac allograft recipients is distinct from that seen during allograft rejection.](https://stanfordhealthcare.org/publications/205/205846.html) Deng, M. C., Mehra, M., Hunt, S., Valantine, H., Miner, R., Phillips, J., ... Eisen, H. J. (2004). Leukocyte gene expression signature of CMV viremia in cardiac allograft recipients is distinct from that seen during allograft rejection. Presented at the 5th American Transplant Congress, BOSTON,MA,MA: WILEY-BLACKWELL. - [Severe tricuspid regurgitation after heart transplant](https://stanfordhealthcare.org/publications/207/207531.html) Chan, M. C. Y., Giannetti, N., Kato, T., Li, Q., Kornbluth, M., Oyer, P., ... Hunt, S. A. (1999). Severe tricuspid regurgitation after heart transplant. CIRCULATION, 100(18), 163-63. - [Improvement in right heart failure after tricuspid valve replacement in cardiac transplant patients](https://stanfordhealthcare.org/publications/207/207554.html) Giannetti, N., Alimollah, A., Kato, T., Chan, M., Cecere, R., Hunt, S. A., ... Robbins, R. C. (1999). Improvement in right heart failure after tricuspid valve replacement in cardiac transplant patients. TRANSPLANTATION, 67(7), S106-S106. - [Gene-Expression Profiling after Cardiac Transplantation REPLY](https://stanfordhealthcare.org/publications/207/207614.html) Pham, M. X., & Valantine, H. A. (2010). Gene-Expression Profiling after Cardiac Transplantation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 363(14), 1374-74. - [Current prevalence of coronary artery disease in kidney transplant candidates with type I diabetes mellitus.](https://stanfordhealthcare.org/publications/207/207949.html) Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., ... Scandling, J. D. (2002). Current prevalence of coronary artery disease in kidney transplant candidates with type I diabetes mellitus. AMER SOC NEPHROLOGY. - [Validation of a screening protocol for coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus.](https://stanfordhealthcare.org/publications/207/207974.html) Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., ... Scandling, J. D. (2002). Validation of a screening protocol for coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus. AMER SOC NEPHROLOGY. - [Long term outcomes in adult heart transplant recipients treated with OKT3 versus daclizumab induction therapy.](https://stanfordhealthcare.org/publications/214/214211.html) Virani, S. A., Ransohoff, K., Haddad, F., Valantine, H. A., & Chin, C. (2007). Long term outcomes in adult heart transplant recipients treated with OKT3 versus daclizumab induction therapy. Presented at the 7th American Transplant Congress, SAN FRANCISCO,CA,CA: WILEY-BLACKWELL. - [Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation](https://stanfordhealthcare.org/publications/214/214472.html) Khazanie, P., Haddad, F., Simos, A. M., Pham, M., Weisshaar, D. M., Desai, S. V., ... Fearon, W. (2009). Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(10), A182-A182. - [Microvascular Drysfunction and Outcome Following Heart Transplantation](https://stanfordhealthcare.org/publications/214/214505.html) Khazanie, P., Haddad, F., Simos, A. M., Weissbaar, D. M., Desai, S. V., Pham, M., ... Fearon, W. (2009). Microvascular Drysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S228-S228. - [DOPPLER ECHOCARDIOGRAPHIC INDEXES OF DIASTOLIC FUNCTION AS MARKERS OF ACUTE CARDIAC REJECTION](https://stanfordhealthcare.org/publications/215/215798.html) Valantine, H., Fowler, M., Hatle, L., Hunt, S., Billingham, M., STINSON, E., & Popp, R. (1987). DOPPLER ECHOCARDIOGRAPHIC INDEXES OF DIASTOLIC FUNCTION AS MARKERS OF ACUTE CARDIAC REJECTION. TRANSPLANTATION PROCEEDINGS, 19(1), 2556-59. - [INFLUENCE OF RECIPIENT ATRIAL CONTRACTION ON LEFT-VENTRICULAR FILLING DYNAMICS OF THE TRANSPLANTED HEART ASSESSED BY DOPPLER ECHOCARDIOGRAPHY](https://stanfordhealthcare.org/publications/216/216813.html) Valantine, H. A., Appleton, C. P., Hatle, L. K., Hunt, S. A., Stinson, E. B., & Popp, R. L. (1987). INFLUENCE OF RECIPIENT ATRIAL CONTRACTION ON LEFT-VENTRICULAR FILLING DYNAMICS OF THE TRANSPLANTED HEART ASSESSED BY DOPPLER ECHOCARDIOGRAPHY. AMERICAN JOURNAL OF CARDIOLOGY, 59(12), 1159-63. - [Changing Trends in Infectious Complications among Heart Transplant Recipients](https://stanfordhealthcare.org/publications/219/219429.html) Haddad, F., Deuse, T., Rosso, P., Pham, M., Khazanie, P., Luikart, H., ... Montoya, J. G. (2009). Changing Trends in Infectious Complications among Heart Transplant Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S237-S238. - [Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection](https://stanfordhealthcare.org/publications/219/219447.html) Potena, L., Holweg, C., Luikart, H., Mocarski, E., Lewis, Cooke, J., ... Valantine, H. (2005). Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(2), S117-S118. - [Cytomegalovirus infection is associated with acute left ventricular dysfunction in heart transplant recipients after antiviral prohylaxis.](https://stanfordhealthcare.org/publications/219/219452.html) Potena, L., Holweg, C. T. J., Luikart, H. I., Levvis, D. B., Cooke, J. P., Mocarski, E. S., & Valantine, H. A. (2005). Cytomegalovirus infection is associated with acute left ventricular dysfunction in heart transplant recipients after antiviral prohylaxis. Presented at the 6th American Transplant Congress, SEATTLE,WA,WA: WILEY-BLACKWELL. - [Systemic inflammation links impaired glucose metabolism to cardiac allograft vasculopathy development](https://stanfordhealthcare.org/publications/219/219456.html) Potena, L., Biadi, O., Fearon, W. B., T., Luikart, H. I., Mocarski, E. S., ... Valantine, H. A. (2004). Systemic inflammation links impaired glucose metabolism to cardiac allograft vasculopathy development. CIRCULATION. NEW ORLEANS,LA,LA,LA,LA,LA: LIPPINCOTT WILLIAMS & WILKINS. - [Multi-center intravascular ultrasound validation study among heart transplant recipients: Outcomes after 5 years.](https://stanfordhealthcare.org/publications/219/219461.html) Kobashigawa, J. A., Tobis, J. M., Starling, R. C., Tuzcu, M. E., Mehra, M. R., Yeung, A., ... Cretin, N. (2004). Multi-center intravascular ultrasound validation study among heart transplant recipients: Outcomes after 5 years. Presented at the 5th American Transplant Congress, BOSTON,MA,MA: WILEY-BLACKWELL. - [Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients](https://stanfordhealthcare.org/publications/219/219472.html) Potena, L., Magelli, C., Fearon, W. F., F., Magnani, G., ... Valantine, H. A. (2004). Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. NEW ORLEANS,LA,LA,LA,LA,LA,LA,LA: ELSEVIER SCIENCE INC. - [Prevention of subclinical CMV infection reduces cardiac allograft disease progression by positively affecting coronary remodeling](https://stanfordhealthcare.org/publications/219/219474.html) Potena, L., Fearon, W., Holweg, C., Luikart, H., Chin, C., Cooke, J., ... Valantine, H. (2006). Prevention of subclinical CMV infection reduces cardiac allograft disease progression by positively affecting coronary remodeling. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(2), S138-S139. - [Asymptomatic cytomegalovirus activation leads to acute rejection in heart transplant recipients despite anti-viral prophylaxis.](https://stanfordhealthcare.org/publications/219/219486.html) Potena, L., Holweg, C., Luikart, H. I., Mocarski, E. S., Cooke, J. P., Lewis, D. B., & Valantine, H. A. (2004). Asymptomatic cytomegalovirus activation leads to acute rejection in heart transplant recipients despite anti-viral prophylaxis. Presented at the 5th American Transplant Congress, BOSTON,MA,MA,MA: WILEY-BLACKWELL. - [Inhibition Sydow, K., Holweg, C., Luikart, H., Mocarski, E., ... and mycofenolate: Asymmetric dimethyl arginine as a potential therapeutic target. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(2), S100-S100. - [Reversibility of diabetes-induced rat graft vasculopathy by metformin.](https://stanfordhealthcare.org/publications/221/221138.html) Cantin, B., Zhu, D. N., Wen, P. Z., Panchal, S. N., Gwathmey, J. K., Reaven, G. M., & Valantine, H. A. (2001). Reversibility of diabetes-induced rat graft vasculopathy by metformin. CIRCULATION, 104(17), 118-18. - [Coronary endothelial dysfunction in cardiac transplant recipients is related to elevated levels of ADMA](https://stanfordhealthcare.org/publications/229/229594.html) Fearon, W. F., Wang, B. Y., Nakamura, M., Potena, L., Valantine, H. A., Yeung, A. C., & Cooke, J. P. (2004). Coronary endothelial dysfunction in cardiac transplant recipients is related to elevated levels of ADMA. CIRCULATION. NEW ORLEANS,LA,LA,LA,LA,LA: LIPPINCOTT WILLIAMS & WILKINS. - [Factors affecting proximal coronary artery remodeling after cardiac transplantation](https://stanfordhealthcare.org/publications/230/230828.html) Bove, A. A., Zhang, X. Y., Valantine, H., Mellein, B., Mueller, E. A., & Eisen, H. J. (2000). Factors affecting proximal coronary artery remodeling after cardiac transplantation. CIRCULATION, 102(18), 817-17. - [Routine Rejection Surveillance by Clinical Assessment and Echocardiography: Insights from the IMAGE Trial.](https://stanfordhealthcare.org/publications/232/232093.html) Teuteberg, J. J., Ewald, G., Pham, M. X., Kfoury, A. G., Starling, R. C., Deng, M. C., ... Valantine, H. A. (2011). Routine Rejection Surveillance by Clinical Assessment and Echocardiography: Insights from the IMAGE Trial. Presented at the American Transplant Congress, PHILADELPHIA,PA,PA: WILEY-BLACKWELL. - [Incidence and Predictors of Late Rejection after Cardiac Transplantation](https://stanfordhealthcare.org/publications/232/232097.html) Pham, M. X., Wolters, H., Baran, D. A., Starling, C., Teuteberg, J. J., Kfoury, A. G., ... Valantine, H. A. (2011). Incidence and Predictors of Late Rejection after Cardiac Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S50-S50. - [Personalized Clinical Rejection Surveillance after Cardiac Transplantation by Longitudinal Gene Expression Profiling](https://stanfordhealthcare.org/publications/232/232100.html) Deng, M. C., Wolters, H., Shahzad, K., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., ... Valantine, H. A. (2011). Personalized Clinical Rejection Surveillance after Cardiac Transplantation by Longitudinal Gene Expression Profiling. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S46-S47. - [Comparison of Gene Expression Profiling and Endomyocardial Biopsy for Surveillance of Acute Cardiac Cellular Rejection: Results from the IMAGE Trial](https://stanfordhealthcare.org/publications/232/232107.html) Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., Cappola, T. P., ... Valantine, H. A. (2010). Comparison of Gene Expression Profiling and Endomyocardial Biopsy for Surveillance of Acute Cardiac Cellular Rejection: Results from the IMAGE Trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(2), S38-S39. - [Do Longitudinal Stable Lower AltoMap (R) Scores Portend Better Outcomes after Heart Transplantation?](https://stanfordhealthcare.org/publications/232/232114.html) Budge, D., Brunisholz, K. D., Wolters, H., Valantine, H. A., Pham, M. X., Teuteberg, J. T., ... Kfoury, A. G. (2011). Do Longitudinal Stable Lower AltoMap (R) Scores Portend Better Outcomes after Heart Transplantation? JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(4), S34-S34. - [Association between non-bacterial J., Behr, M., Remmington, J., Valantine, H. A., & Hunt, S. A. (1998). Association between non-bacterial infections and cardiac allograft atherosclerosis. CIRCULATION, 98(17), 692-92. - [Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: A multicenter prospective intravascular ultrasound study](https://stanfordhealthcare.org/publications/234/234701.html) Wong, C. K., Schwarzkopf, A., Kobashagawa, J., Miller, L., Valantine, H., Ventura, H., ... Yeung, A. C. (1996). Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: A multicenter prospective intravascular ultrasound study. CIRCULATION, 94(8), 1687-87. - [Endothelial nitric oxide synthesis is severely impaired after cardiac transplantation: Role of ADMA](https://stanfordhealthcare.org/publications/234/234728.html) Fearon, W. F., Wang, B. Y., Valantine, H. A., Mocarsky, E. S., Yeung, A. C., & Cooke, J. P. (2003). Endothelial nitric oxide synthesis is severely impaired after cardiac transplantation: Role of ADMA. CIRCULATION, 108(17), 303-. - [Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation](https://stanfordhealthcare.org/publications/237/237067.html) Zuckermann, A., Manito, N., Epailly, J. F., ... Valantine, H. (2008). Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 27(2), 141-49. - [Invasive Monitoring Attenuation through Gene Expression (IMAGE) Trial: Current Enrollment and Study Progress.](https://stanfordhealthcare.org/publications/246/246485.html) Pham, M. X., Deng, M. C., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Anderson, A., ... Valantine, H. A. (2009). Invasive Monitoring Attenuation through Gene Expression (IMAGE) Trial: Current Enrollment and Study Progress. Presented at the 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, BOSTON,MA,MA: WILEY-BLACKWELL. - [Early detection of Cardiac Allograft Vasculopathy through gene expression - Profiling insights of the cargo study](https://stanfordhealthcare.org/publications/246/246491.html) Deng, M. C., Cadeiras, M., Baron, H. M., Marboe, H. M., Starling, R. C., Eisen, H., ... Dedrick, R. (2006). Early detection of Cardiac Allograft Vasculopathy through gene expression - Profiling insights of the cargo study. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(2), S98-S98. - [Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.](https://stanfordhealthcare.org/publications/253/253403.html) Vrtovec, B., Haddad, F., Pham, M., Deuse, T., Fearon, W. F., Schrepfer, S., ... Hunt, S. A. (2013). Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. Transplantation Proceedings, 45(6), 2406-9. - [Three-year results of a randomized, double-blind, controlled mycophenolate mofetil versus azathioprine in cardiac transplant recipients](https://stanfordhealthcare.org/publications/253/253677.html) Eisen, H. Kobashigawa, J., Keogh, A., Bourge, R., Renlund, D., Mentzer, R., ... Johnson, J. (2005). Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(5), 517-25. - [A randomized Kobashigawa, J., Miller, L., D., Mentzer, R., Alderman, Bourge, R., ... (1998). A randomized active-controlled trial mycophenolate in heart transplant recipients. TRANSPLANTATION, 66(4), 507-15. - [The impact of brain death on survival after heart transplantation: Time is of the essence](https://stanfordhealthcare.org/publications/264/264708.html) Cantin, B., Kwok, B. W. K., Chan, M. C. Y., Valantine, H. A., Oyer, P. E., Robbins, R. C., & Hunt, S. A. (2003). The impact of brain death on survival after heart transplantation: Time is of the essence. TRANSPLANTATION, 76(9), 1275-79. - [Temporal response of the human virome to immunosuppression and antiviral therapy.](https://stanfordhealthcare.org/publications/273/273847.html) De Vlaminck, I., Khush, K. K., Strehl, C., Kohli, B., Luikart, H., Neff, N. F., ... Quake, S. R. (2013). Temporal response of the human virome to immunosuppression and antiviral therapy. Cell, 155(5), 1178-87. - [Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.](https://stanfordhealthcare.org/publications/285/285207.html) Li, L., Khush, K., Hsieh, S.-C., Ying, L., Luikart, H., Sigdel, T., ... Sarwal, M. M. (2013). Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection. PloS One, 8(12). - [Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients.](https://stanfordhealthcare.org/publications/308/308529.html) Deng, M. C., Elashoff, B., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., ... Valantine, H. A. (2014). Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients. Transplantation, 97(6), 708-14. - [The gender gap in academic medicine: comparing results from a multifaceted intervention for stanford faculty to peer and national cohorts.](https://stanfordhealthcare.org/publications/310/310118.html) Valantine, H. A., Grewal, D., Ku, M. C., Moseley, J., Shih, M.-C., Stevenson, D., & Pizzo, P. A. (2014). The gender gap in academic medicine: comparing results from a multifaceted intervention for stanford faculty to peer and national cohorts. Academic Medicine , 89(6), 904-11. - [Circulating Cell-Free DNA Enables Heart Transplant Rejection](https://stanfordhealthcare.org/publications/321/321854.html) De Vlaminck, I., Valantine, H. A., Snyder, T. M., Strehl, C., Cohen, G., Luikart, H., ... Khush, K. K. (2014). Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection. SCIENCE TRANSLATIONAL MEDICINE, 6(241). - [Identification of Common Blood Gene Signatures for the Diagnosis of Renal and Cardiac Acute Allograft Rejection](https://stanfordhealthcare.org/publications/322/322341.html) Li, L., Khush, K., Hsieh, S.-C., Ying, L., Luikart, H., Sigdel, T., ... Sarwal, M. M. (2013). Identification of Common Blood Gene Signatures for the Diagnosis of Renal and Cardiac Acute Allograft Rejection. PLOS ONE, 8(12). - [Circulating cell-free DNA enables diagnosis of heart transplant rejection.](https://stanfordhealthcare.org/publications/323/323097.html) De Vlaminck, I., Valantine, H. A., Snyder, T. M., Strehl, C., Cohen, G., Luikart, H., ... Khush, K. K. (2014). Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Science Translational Medicine, 6(241), 241ra77-? - [Multicenter intravascular ultrasound validation study among heart transplant recipients - Outcomes after five years](https://stanfordhealthcare.org/publications/358/358873.html) Kobashigawa, J. A., Tobis, J. M., Starling, R. C., Tuzcu, E. M., Smith, A. L., Valantine, H. A., ... Cretin, N. (2005). Multicenter intravascular ultrasound validation study among heart transplant recipients - Outcomes after five years. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45(9), 1532-37. - [Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound](https://stanfordhealthcare.org/publications/358/358936.html) Kobashigawa, J. A., Miller, L., Yeung, A., Hauptman, P., Ventura, H., Wilensky, R., ... Wiedermann, J. (1995). Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14(6), S221-S226. - [Everolimus (certican) in heart transplantation: Optimizing renal function through minimizing cyclosporine exposure](https://stanfordhealthcare.org/publications/359/359590.html) Lehmkuhl, H., Ross, H., Eisen, H., & Valantine, H. (2005). Everolimus (certican) in heart transplantation: Optimizing renal function through minimizing cyclosporine exposure. TRANSPLANTATION PROCEEDINGS, 37(10), 4145-49. - [The impact of cyclosporine dose and level on the development and progression of allograft coronary disease](https://stanfordhealthcare.org/publications/359/359597.html) Miller, L., Kobashigawa, J., Valantine, H., Ventura, H., Hauptman, P., ODONNELL, J., ... Yeung, A. (1995). The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14(6), S227-S234. - [Improving outcomes in heart transplantation: The potential of proliferation signal inhibitors](https://stanfordhealthcare.org/publications/359/359598.html) Eisen, H., Kobashigawa, J., Starling, R. C., Valantine, H., & Mancini, D. (2005). Improving outcomes in heart transplantation: The potential of proliferation signal inhibitors. TRANSPLANTATION PROCEEDINGS, 37(4), 4S-17S. - [Cardiac allograft vasculopathy and insulin resistance - Hope for new therapeutic targets](https://stanfordhealthcare.org/publications/359/359599.html) Potena, L., & Valantine, H. A. (2007). Cardiac allograft vasculopathy and insulin resistance - Hope for new therapeutic targets. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 36(4), 965-? - [Safety, tolerability and efficacy of heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation](https://stanfordhealthcare.org/publications/359/359601.html) Eisen, H. J., Hobbs, R. E., Davis, S. F., Laufer, G., Mancini, D. M., Renlund, D. G., ... Mueller, E. A. (1999). Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation. TRANSPLANTATION. CHICAGO,IL,IL,IL,IL,IL,IL: LIPPINCOTT WILLIAMS & WILKINS. - [Gene expression profiling to study racial differences after heart transplantation](https://stanfordhealthcare.org/publications/382/382386.html) Khush, K. K., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Deng, M. C., Kao, A., ... Valantine, H. A. (2015). Gene expression profiling to study racial differences after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 34(7), 970-77. - [Noninvasive monitoring of infection and rejection after lung transplantation.](https://stanfordhealthcare.org/publications/392/392575.html) De Vlaminck, I., Martin, L., Kertesz, M., Patel, K., Kowarsky, M., Strehl, C., ... Quake, S. R. (2015). Noninvasive monitoring of infection and rejection after lung transplantation. Proceedings of the National Academy of Sciences of the United States of America, 112(43), 13336-41. - [Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation.](https://stanfordhealthcare.org/publications/395/395458.html) Okada, K., Kitahara, H., Yang, H.-M., Tanaka, S., Kobayashi, Y., Kimura, T., ... Fearon, W. F. (2015). Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. JACC. Heart Failure, 3(12), 942-52. - [Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty](https://stanfordhealthcare.org/publications/395/395515.html) Fassiotto, M., Hamel, E. O., Ku, M., Correll, S., Grewal, D., Lavori, P., ... Valantine, H. (2016). Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty. JOURNAL OF WOMENS HEALTH, 25(3), 292-98. - [Reducing Implicit Gender Leadership Bias in Academic Medicine With an Educational Intervention.](https://stanfordhealthcare.org/publications/397/397625.html) Girod, S., Fassiotto, M., Grewal, D., Ku, M. C., Sriram, N., Nosek, B. A., & Valantine, H. (2016). Reducing Implicit Gender Leadership Bias in Academic Medicine With an Educational Intervention. Academic Medicine , 91(8), 1143-50. - [Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation](https://stanfordhealthcare.org/publications/397/397725.html) Okada, K., Kitahara, H., Yang, H.-M., Tanaka, S., Kobayashi, Y., Kimura, T., ... Fearon, W. F. (2015). Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. JACC-HEART FAILURE, 3(12), 942-52. - [Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study](https://stanfordhealthcare.org/publications/400/400324.html) Vollmers, C., De A., Penland, L., Luikart, H., Strehl, C., ... Quake, S. R. (2015). Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study. PLOS MEDICINE, 12(10). - [Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation](https://stanfordhealthcare.org/publications/404/404742.html) Yang, H.-M., Khush, K., Luikart, H., Okada, K., Lim, H.-S., Kobayashi, Y., ... Fearon, W. F. (2016). Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation. CIRCULATION, 133(20), 1945-50. - [Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.](https://stanfordhealthcare.org/publications/416/416205.html) Okada, K., Fearon, W. F., Luikart, H., Kitahara, H., Otagiri, K., Tanaka, S., ... Honda, Y. (2016). Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. Journal of the American College of Cardiology, 68(4), 382-92. - [Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma](https://stanfordhealthcare.org/publications/416/416261.html) Burnham, P., Kim, M. S., Agbor-Enoh, S., Luikart, H., Valantine, H. A., Khush, K. K., & De Vlaminck, I. (2016). Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. SCIENTIFIC REPORTS, 6. - [Proliferation signal inhibitors in transplantation: Questions at the cutting edge of everolimus therapy](https://stanfordhealthcare.org/publications/416/416262.html) Chapman, J. R., Valantine, H., Albanell, J., A., Campistol, J. M., Eisen, H., ... Zuckermann, A. (2007). Proliferation signal inhibitors in transplantation: Questions at the cutting edge of everolimus therapy. TRANSPLANTATION PROCEEDINGS, 39(10), 2937-50. - [Designing a physician leadership development program based on effective models of physician education.](https://stanfordhealthcare.org/publications/430/430574.html) Hopkins, J., Fassiotto, M., Ku, M. C., Mammo, D., & Valantine, H. (2017). Designing a physician leadership development program based on effective models of physician education. Health Care Management Review. - [Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy.](https://stanfordhealthcare.org/publications/431/431099.html) Lee, J. H., Okada, K., Khush, K., Kobayashi, Y., Sinha, S., Luikart, H., ... Fearon, W. F. (2017). Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy. Circulation, 135(11), 1093-95. - [Angiotensin-Converting Transplantation.](https://stanfordhealthcare.org/publications/442/442632.html) Fearon, W. F., Okada, K., Kobashigawa, J. A., Kobayashi, K. (2017). Angiotensin-Converting Enzyme Inhibition Early After Heart Journal of the American College of Cardiology, 69(23), 2832-41. - [Impact of Asymmetric Dimethylarginine on Early After Heart Transplantation.](https://stanfordhealthcare.org/publications/448/448361.html) Parikh, R. V., Khush, K. K., Luikart, H., Pargaonkar, V. S., Kobayashi, Y., Lee, J. H., ... Fearon, W. F. (2017). Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation. The American Journal of Cardiology. - [An Integrated Career Coaching and Time Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine](https://stanfordhealthcare.org/publications/454/454696.html) Fassiotto, M., Simard, C., Sandborg, C., Valantine, H., & Raymond, J. (2018). An Integrated Career Coaching and Time Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine. Academic Medicine. - [Long-term prognostic value of invasive and non-invasive measures early after heart transplantation.](https://stanfordhealthcare.org/publications/458/458154.html) Kobayashi, Y., Kobayashi, Y., Yang, H.-M. M., Bouajila, S., Luikart, H., Nishi, T., ... Fearon, W. F. (2018). Long-term prognostic value of invasive and non-invasive measures early after heart transplantation. International Journal of Cardiology, 260, 31-35. - [Pulled in Too Many Directions: The Causes and Consequences of Work-Work Conflict](https://stanfordhealthcare.org/publications/465/465127.html) Wynn, A. T., Fassiotto, M., Simard, C., Raymond, J. L., & Valantine, H. (2018). Pulled in Too Many Directions: The Causes and Consequences of Work-Work Conflict. Sociological Perspectives. - [Changing the Culture of Academic Medicine to Eliminate the Gender Leadership Gap: 50/50 by 2020](https://stanfordhealthcare.org/publications/465/465528.html) Valantine, H., & Sandborg, C. I. (2013). Changing the Culture of Academic Medicine to Eliminate the Gender Leadership Gap: 50/50 by 2020. ACADEMIC MEDICINE, 88(10), 1411-13. - [IMPACT OF ENDOTHELIN-1 ON CARDIAC FOLLOWING HEART TRANSPLANTATION](https://stanfordhealthcare.org/publications/466/466403.html) Parikh, R., Khush, K., Luikart, H., Grimm, D., Yu, M., Yeung, A., ... Fearon, W. (2018). IMPACT OF ENDOTHELIN-1 ON CARDIAC ALLOGRAFT VASCULOPATHY, LATE MORTALITY AND RE-TRANSPLANTATION FOLLOWING HEART TRANSPLANTATION. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(11), 2667. - [Late manifestation of alloantibody-associated injury antibody-mediated rejection: Evidence from cell-free DNA analysis](https://stanfordhealthcare.org/publications/477/477513.html) Agbor-Enoh, S., Jackson, A. M., Tunc, I., Berry, G. J., Cochrane, A., Grimm, D., ... Khush, K. (2018). Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 37(7), 925-32. - [Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation.](https://stanfordhealthcare.org/publications/492/492598.html) Parikh, R. V., Khush, K., Pargaonkar, V. S., Luikart, H., Grimm, D., Yu, M., ... Fearon, W. F. (2018). Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation. Journal of Cardiac Failure. - [Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation](https://stanfordhealthcare.org/publications/492/492861.html) Parikh, R., Khush, K., Luikart, H., Sakarovitch, C., Lee, J., Desai, M., ... Fearon, W. F. (2018). Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation. AMERICAN JOURNAL OF CARDIOLOGY, 122(10), 1707-11. - [Donor-derived cell-free DNA predicts allograft failure mortality after lung transplantation.](https://stanfordhealthcare.org/publications/495/495633.html) Agbor-Enoh, S., Wang, Y., Tunc, I., Jang, M. K., Davis, A., De Vlaminck, I., ... Valantine, H. A. (2019). Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation. EBioMedicine. - [The effect of negative remodeling on fractional flow reserve after cardiac transplantation](https://stanfordhealthcare.org/publications/501/501135.html) Fearon, W. F., Felix, R., Hirohata, A., Sakurai, R., Jose, P. O., Yamasaki, M., ... Yeung, A. C. (2017). The effect of negative remodeling on fractional flow reserve after cardiac transplantation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 241, 283-87. - [Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation](https://stanfordhealthcare.org/publications/504/504302.html) Agbor-Enoh, S., Tunc, I., De Vlaminck, I., A., Cuttin, K., ... Valantine, rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 36(9), 1004-12. - [Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype](https://stanfordhealthcare.org/publications/504/504303.html) Sharon, E., Shi, H., Kharbanda, S., Koh, W., Martin, L. R., Khush, K. K., ... De Vlaminck, I. (2017). Quantification of transplant-derived circulating cell-free DNA in of donor genotype. PLOS COMPUTATIONAL BIOLOGY, 13(8), e1005629. - [Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation.](https://stanfordhealthcare.org/publications/508/508976.html) Okada, K., Honda, Y., Luikart, H., Yock, P. G., Fitzgerald, P. J., Yeung, A. C., ... Fearon, W. F. (2019). Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation. International Journal of Cardiology. - [Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty.](https://stanfordhealthcare.org/publications/510/510651.html) Fassiotto, M., Hamel, E. O., Ku, M., Correll, S., Grewal, D., Lavori, P., ... Valantine, H. (2015). Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty. Journal of Women's Health (2002). - [An Integrated Career Coaching and Time-Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine.](https://stanfordhealthcare.org/publications/510/510782.html) Fassiotto, M., Simard, C., Sandborg, C., Valantine, H., & Raymond, J. (2018). An Integrated Career Coaching and Time-Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine. Academic Medicine : Journal of the Association of American Medical Colleges, 93(6), 881-887. - [Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation](https://stanfordhealthcare.org/publications/750/750808.html) Okada, K., Honda, Y., Luikart, H., Yock, P. G., Fitzgerald, P. J., Yeung, A. C., ... Fearon, W. F. (2019). Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 290, 27-32. - [De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.](https://stanfordhealthcare.org/publications/757/757794.html) Deuse, T., Hu, X., Agbor-Enoh, S., Koch, M., Spitzer, M. H., Gravina, A., ... Schrepfer, S. (2019). De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans. Nature Biotechnology. - [NHLBI-SPONSORED PROSPECTIVE STUDY TO VALIDATE THE USE OF DONOR-DERIVED CELL-FREE DNA TO DETECT LUNG-TRANSPLANT REJECTION - INTERIM RESULTS](https://stanfordhealthcare.org/publications/764/764019.html) Agbor, S., Berry, G., Marboe, C., Tunc, I., Jackson, A., Shah, P., ... Valantine, H. (2019). NHLBI-SPONSORED PROSPECTIVE STUDY TO VALIDATE THE USE OF DONOR-DERIVED CELL-FREE DNA TO DETECT LUNG-TRANSPLANT REJECTION - INTERIM RESULTS. HUMAN IMMUNOLOGY, 80, 25-26. - [Transcriptomics in transplantation: More than just biomarkers of allograft rejection.](https://stanfordhealthcare.org/publications/800/800421.html) Shah, P., Valantine, H. A., & Agbor-Enoh, S. (2020). Transcriptomics in transplantation: More than just biomarkers of allograft rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. - [Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous Pandemics.](https://stanfordhealthcare.org/publications/801/801776.html) Fassiotto, M., Valantine, H., Shanafelt, T., & Maldonado, Y. (2020). Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous Pandemics. Academic Medicine : Journal of the Association of American Medical Colleges, Publish Ahead of Print. - [The SIRPa-CD47 immune checkpoint in NK cells.](https://stanfordhealthcare.org/publications/802/802516.html) Deuse, T., Hu, X., Agbor-Enoh, S., Jang, M. K., Alawi, M., Saygi, C., ... Schrepfer, S. (2021). The SIRPa-CD47 immune checkpoint in NK cells. The Journal of Experimental Medicine, 218(3). - [Cell-Free DNA to Detect Heart Allograft Acute Rejection.](https://stanfordhealthcare.org/publications/803/803229.html) Agbor-Enoh, S., Shah, P., Tunc, I., Hsu, S., Russell, S., Feller, E., ... Valantine, H. A. (2021). Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation. - [The COVID-19 Vaccine and the Black Community: Addressing the Justified Questions.](https://stanfordhealthcare.org/publications/817/817846.html) Laurencin, C. T., Valantine, H., Yancy, C., Jones, C. P., & Bright, C. (2021). The COVID-19 Vaccine and the Black Community: Addressing the Justified Questions. Journal of Racial and Ethnic Health Disparities. - [A Pioneer in Transplantation Genomics, Inclusion, and Diversity A Conversation With Hannah Valantine, MBBS, MD](https://stanfordhealthcare.org/publications/819/819549.html) Valantine, H., & Farr, M. (2021). A Pioneer in Transplantation Genomics, Inclusion, and Diversity A Conversation With Hannah Valantine, MBBS, MD. CIRCULATION, 143(24), 2321-2326. - [Response by Shah et al to Letter Regarding Article, \"Cell-Free DNA to Detect Heart Allograft Acute Rejection\".](https://stanfordhealthcare.org/publications/826/826207.html) Shah, P., Agbor-Enoh, S., Tunc, I., Hsu, S., Russell, S., Feller, E., ... Valantine, H. A. (2021). Response by Shah et al to Letter Regarding Article, \"Cell-Free DNA to Detect Heart Allograft Acute Rejection\". Circulation, 144(10), e198-e199. - [Ending Sexual Harassment in Science: Designing and Administering a Survey That Can Lead to an Improved Organizational Climate.](https://stanfordhealthcare.org/publications/830/830993.html) Valantine, H. A., Le Fauve, C. E., Morris, K. A., & Riley, W. T. (2021). Ending Sexual Harassment in Science: Designing and Administering a Survey That Can Lead to an Improved Organizational Climate. Academic Medicine : Journal of the Association of American Medical Colleges. - [Can We Predict Rejection Early After Heart Transplantation?](https://stanfordhealthcare.org/publications/831/831516.html) Fearon, W. F., & Valantine, H. A. (2021). Can We Predict Rejection Early After Heart Transplantation? Circulation, 144(18), 1473-1475. - [A commitment to scientific equity from a philanthropic funder.](https://stanfordhealthcare.org/publications/832/832165.html) Bargmann, C., Claiborne, A., & Valantine, H. (2021). A commitment to scientific equity from a philanthropic funder. Nature Medicine. - [Higher levels of allograft injury in black patients early after heart transplantation.](https://stanfordhealthcare.org/publications/837/837024.html) Doshi, A., Shah, K. B., Agbor-Enoh, S., Tushak, Z., Garcia, V., Kong, H., ... Valantine, H. A. (1800). Higher levels of allograft injury in black patients early after heart transplantation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. - [Circulating microRNAs in cellular and antibody-mediated heart transplant rejection.](https://stanfordhealthcare.org/publications/852/852666.html) Shah, P., Agbor-Enoh, S., Bagchi, C. ... H. A. (2022). Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. - [Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.](https://stanfordhealthcare.org/publications/855/855284.html) Brusca, S. B., Elinoff, J. M., Zou, Y., Jang, M. K., Kong, H., Demirkale, C. Y., ... Solomon, M. A. (2022). Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension. Circulation, 101161CIRCULATIONAHA121056719. - [Equity in Transplantation: A Commitment for Progress in Troubled Times](https://stanfordhealthcare.org/publications/856/856920.html) Berney, T., Ulasi, I. I., Balleste, C., Martins, P. N., Bellini, M. I., Valantine, H. A., & Potena, L. (2022). Equity in Transplantation: A Commitment for Progress in Troubled Times. TRANSPLANT INTERNATIONAL, 35, 10781. - [Applying Genomics to Unravel Health Disparities in Organ Transplantation: Paul I. Terasaki State-of-the-art Lecture; American Transplant Congress 2021.](https://stanfordhealthcare.org/publications/867/867269.html) Valantine, H. A. (2022). Applying Genomics to Unravel Health Disparities in Organ Transplantation: Paul I. Terasaki State-of-the-art Lecture; American Transplant Congress 2021. Transplantation. - [The Time to Act Is Now: Racial Disparities After Heart Transplantation.](https://stanfordhealthcare.org/publications/882/882896.html) Khush, K. K., & Valantine, H. A. (2023). The Time to Act Is Now: Racial Disparities After Heart Transplantation. Circulation, 148(3), 207-209. - [Hannah A. Valantine, MD, Stanford University School of Medicine](https://stanfordhealthcare.org/publications/883/883641.html) Valantine, H. A. (2023). Hannah A. Valantine, MD, Stanford University School of Medicine. CELL, 186(12), 2524-2526. - [Time to open up](https://stanfordhealthcare.org/publications/884/884167.html) Elovitz, M., Quake, S., & Valantine, H. (2023). Time to open up. NEW SCIENTIST, 246(3444), 21. Clinical Trials Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials. Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future. - [IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection \u00bb](https://stanfordhealthcare.org/trials/i/NCT00351559.html) - [Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation \u00bb](https://stanfordhealthcare.org/trials/c/NCT01186250.html) - [Genome Transplant Dynamics: Sequencing-based Diagnosis of Rejection (ACE) Inhibition and Cardiac Allograft Vasculopathy \u00bb](https://stanfordhealthcare.org/trials/a/NCT01078363.html) Practice Locations Heart Transplant Program Stanford, CAStanford, CA Heart Transplant Program 300 Pasteur Drive , 2nd Floor, Room A21 Stanford [Getting Here \u00bb](https://stanfordhealthcare.org/medical-clinics/heart-transplant-program.mapmodal.html) Important Information about Our Organizations and Physician Affiliation Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions. Referring Physicians PHYSICIAN HELPLINE Fax: 650-320-9443 Monday-Friday, 8 a.m.-5 p.m. Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit [Referring Physicians](https://stanfordhealthcare.org/health-care-professionals/physician-referral-center/contact-us.html). You may also submit a [web referral](https://stanfordhealthcare.org/health-care-professionals/physician-referral-center/referral-request-form.html) or complete a referral form and fax it to [650-320-9443](tel:650-320-9443) or email the Referral Center at [ReferralCenter@stanfordhealthcare.org](mailto:ReferralCenter@stanfordhealthcare.org). - Send referrals online - View referral status - Access medical records [Learn More "}